TSPO and fibromyalgia: In this context, PET imaging may help define biologically distinct subgroups of fibromyalgia patients based on patterns of neuroinflammation (e.g., TSPO expression), neurotransmitter dysregulation (e.g., serotonergic or dopaminergic transporter availability), or regional metabolic alterations.